EP-1713: Treatment response assessment using RECIST and toxicity of SABR in extracranial metastatic disease

Autor:	R. De Haro Piedra, S. Velazquez Miranda, J.M. Nieto-Guerrero Gómez, D.M. Muñoz Carmona, E. Montero Perea, M.J. Ortiz Gordillo
Rok vydání:	2018
Předmět:	Oncology medicine.medical_specialty Treatment response business.industry Internal medicine Toxicity medicine Radiology Nuclear Medicine and imaging Hematology Disease business SABR volatility model
Zdroj:	Radiotherapy and Oncology. 127:S918-S919
ISSN:	0167-8140
DOI:	10.1016/s0167-8140(18)32022-x
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::55eb312920531bbaa4ff82c59362592c https://doi.org/10.1016/s0167-8140(18)32022-x Zobrazit plný text záznamu Full Text from ScienceDirect